查看最新行情

　　美东时间周三早间，CVS Health股价大涨，此前该公司报告称第四财季盈利降幅小于预期，因为其医疗成本增长步伐放缓，药房业务收入跃升。

　　该公司未能实现2024年前三个季度的盈利目标，因为它是受65岁及以上或残疾人医疗保险业务成本飙升打击最严重的公司之一。去年，该公司的股价下跌了40%以上。

　　CVS预计年度利润在每股5.75美元至6.00美元之间。分析师平均预期为5.96美元。

　　该公司的医疗保健福利部门公布的季度亏损为4.39亿美元，而一年前的利润为6.76亿美元。

　　Novare资本管理公司高级副总裁James Harlow表示，CVS公司对未来前景的预测可能是保守的，而且是可以超越的，这与过去几年形成鲜明对比，过去几年CVS会提出乐观的前景，随后降低目标。

海量资讯、精准解读，尽在新浪财经APP

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.